Atai Beckley N.V

General ticker "ATAI" information:

  • Sector: Health Care
  • Industry: Medical - Pharmaceuticals
  • Capitalization: $526.3M (TTM average)

Atai Beckley N.V follows the US Stock Market performance with the rate: 52.8%.

Estimated limits based on current volatility of 3.8%: low 3.44$, high 3.71$

Factors to consider:

  • Earnings expected soon, date: 2026-03-16 bmo
  • Total employees count: 54 (-34.9%) as of 2024
  • Top business risk factors: Need for additional capital, Dependence on key products, Regulatory and compliance, Cybersecurity threats, Investment company act risk
  • Current price 75.2% above estimated high
  • Earnings for 9 months up through Q3 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

  • 2024-12-31 to 2025-12-31 estimated range: [0.85$, 2.11$]
  • 2025-12-31 to 2026-12-31 estimated range: [0.82$, 2.02$]

Financial Metrics affecting the ATAI estimates:

  • Positive: with PPE of -1.3 at the end of fiscal year the price was neutral
  • Negative: negative Operating income
  • Negative: Operating cash flow per share per price, % of -41.11 <= 0.01
  • Positive: Investing cash flow per share per price, % of 29.51 > -0.63
  • Positive: Interest expense per share per price, % of 1.56 <= 3.28
  • Positive: Industry inventory ratio change (median), % of -0.45 <= -0.16
  • Negative: negative Net income

Similar symbols

Short-term ATAI quotes

Long-term ATAI plot with estimates

Financial data

YTD 2023-12-31 2024-12-31
Operating Revenue $0.31MM $0.31MM
Operating Expenses $125.78MM $103.00MM
Operating Income $-125.47MM $-102.69MM
Non-Operating Income $82.59MM $-47.71MM
Interest Expense $2.66MM $3.12MM
R&D Expense $62.20MM $55.45MM
Income(Loss) $-42.88MM $-150.41MM
Taxes $1.02MM $-0.36MM
Profit(Loss)* $-40.22MM $-149.27MM
Stockholders Equity $242.96MM $116.30MM
Assets $293.48MM $159.39MM
Operating Cash Flow $-84.12MM $-82.44MM
Capital expenditure $0.59MM $0.10MM
Investing Cash Flow $-53.30MM $59.17MM
Financing Cash Flow $-8.36MM $5.37MM
Earnings Per Share** $-0.25 $-0.93

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.